Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Together we form an independent, bold investment group bound together by a simple word – life. Our mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently manages approximately $295 million.
Location: United States, Massachusetts, Boston
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Series A; Series B
Portfolio 37
| Date | Name | Website | Total Raised | Location |
| 20.09.2024 | LB Pharmac... | lbpharma.us | - | - |
| 16.09.2024 | Third Arc ... | thirdarcbio.com | $165M | - |
| 16.09.2024 | Halda Ther... | haldatx.com | $126M | United Sta... |
| 13.04.2024 | Peloton Th... | pelotontherapeutics.com | $40.2M | - |
| 13.04.2024 | InduPro | induprotx.com | $85M | United Sta... |
| 13.04.2024 | Capstan Th... | capstantx.com | $175M | United Sta... |
| 03.11.2023 | Avalyn Pha... | avalynpharma.com | $210.5M | United Sta... |
| 22.03.2022 | Affini-T | affinittx.com | $175M | United Sta... |
| 10.02.2022 | Alterome T... | alterome.com | $232M | United Sta... |
| 01.02.2022 | Centessa P... | centessa.com | $250M | United Kin... |
Show more
Persons 20
| Date | First Name | Last Name | Title | Location | |||
| - | Chanel | Enz | Accounting... | - | - | - | |
| - | Rajul | Jain, M.D. | Managing D... | - | - | - | |
| - | Arie | Belldegrun... | Co-Founder... | - | - | - | |
| - | Jean-Phili... | (JP) Kouak... | Chief Fina... | - | - | - | |
| - | Scott | Garland | Venture Pa... | - | - | - | |
| - | Victoria | Stephens | Senior Con... | - | - | - | |
| - | Jill | Goldstein,... | Senior Ass... | - | - | - | |
| - | Chris | Weyrer, M.... | Principal | - | - | - | |
| - | Christine | Cassiano | Strategic ... | - | - | - | |
| - | Alex | Loftis, Ph... | Senior Ass... | - | - | - |
Show more
News 128
Show more
Mentions in press and media 20
| Date | Title | Description |
| 29.07.2024 | Scorpion Therapeutics: A Bold Leap in Precision Oncology | Scorpion Therapeutics is making waves in the world of cancer treatment. With a recent $150 million Series C funding round, the Boston-based biotech is poised to redefine the landscape of precision oncology. This funding is not just a financ... |
| 27.07.2024 | Scorpion Therapeutics Raises $150 Million For Enhancing Clinical-Stage Precision Oncology Pipeline | Scorpion Therapeutics, a clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision oncology, announced the closing of a $150 million Series C financing. The funding was co... |
| 25.07.2024 | Canadian Startups Surge: Clio and Third Arc Bio Lead the Charge** ** | ** In the world of startups, the spotlight often shines brightest on Silicon Valley. Yet, this week, Canadian startups have taken center stage, proving that innovation knows no borders. Two companies, Clio and Third Arc Bio, have made headl... |
| 23.07.2024 | Third Arc Bio Launches with Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors and Inflammatory & Immunology (I&I) Diseases | -- Company formed and originally seeded by Omega Funds, Series A financing with exceptional syndicate led by Vida Ventures -- World-class leadership team led by Peter F. Lebowitz, MD, PhD, Sanjaya Singh, PhD, and Joe Erhardt, PhD, well-posi... |
| 23.07.2024 | Third Arc Bio launches with $165M to address unmet needs in oncology and autoimmunity | The company was founded by executives from Johnson & Johnson Third Arc Bio is a company that says its on mission to deliver transformational therapies for solid tumors and inflammatory & immunology diseases through the use of multif... |
| 23.05.2024 | Venture Leaders Biotech 2024: Captains Blog by Maria Van Dongen, CEO of Allegria Therapeutics, and Gabriel Liguori, CEO of TissueLabs | Venture Leaders Biotech 2024: Captains Blog by Maria Van Dongen, CEO of Allegria Therapeutics, and Gabriel Liguori, CEO of TissueLabs 23.05.2024 12:30, Rita Longobardi linkedIn facebook twitter instagram youtube --> In mid-May, the ten V... |
| 22.03.2022 | Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations | - |
| 04.07.2021 | Vida Ventures Closes Fund III, At $825M | Vida Ventures Leadership (from left to right): Rajul Jain, Stefan Vitorovic, Arjun Goyal, Arie Belldegrun, Jean-Philippe Kouakou-Zebouah, Helen S. Kim (Photo: Business Wire) Vida Ventures, a Los Angeles, CA- and Boston, MA-based life scienc... |
| 24.06.2021 | Andreessen Horowitz gears up for more mega crypto bets | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content The gender pay gap and your investment strategies From Refinitiv Venture capitalists... |
| 24.06.2021 | Andreessen Horowitz gears up for more mega crypto bets | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Change your marketer experience and unleash growth for your business From Optimizely... |
Show more